Compound heterozygous HAX1 mutations in a Swedish patient with severe congenital neutropenia and no neurodevelopmental abnormalities

Kostmann disease or severe congenital neutropenia (SCN) is an autosomal recessive disorder of neutrophil production. Homozygous HAX1 mutations were recently identified in SCN patients belonging to the original family in northern Sweden described by Kostmann. Moreover, recent studies have suggested an association between neurological dysfunction and HAX1 deficiency. Here we describe a patient with a compound heterozygous HAX1 mutation consisting of a nonsense mutation (c.568C > T, p.Glu190X) and a frame‐shift mutation (c.91delG, p.Glu31LysfsX54) resulting in a premature stop codon. The patient has a history of neutropenia and a propensity for infections, but has shown no signs of neurodevelopmental abnormalities. Pediatr Blood Cancer 2009;53:1143–1146. © 2009 Wiley‐Liss, Inc.

[1]  Asim Khwaja,et al.  Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds , 2009, British journal of haematology.

[2]  J. Palmblad,et al.  Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations , 2008, Journal of internal medicine.

[3]  M. Ohtsubo,et al.  Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene , 2008, Journal of Medical Genetics.

[4]  Bodo Grimbacher,et al.  Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. , 2008, Blood.

[5]  J. Opferman,et al.  Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons , 2008, Nature.

[6]  O. Ohara,et al.  Severe developmental delay and epilepsy in a Japanese patient with severe congenital neutropenia due to HAX1 deficiency , 2007, Haematologica.

[7]  N. Rezaei,et al.  Association of HAX1 Deficiency with Neurological Disorder , 2007, Neuropediatrics.

[8]  J. Palmblad,et al.  Kostmann syndrome or infantile genetic agranulocytosis, part two: understanding the underlying genetic defects in severe congenital neutropenia , 2007, Acta paediatrica.

[9]  J. Palmblad,et al.  Low plasma levels of the protein pro‐LL‐37 as an early indication of severe disease in patients with chronic neutropenia , 2007, British journal of haematology.

[10]  Bengt Fadeel,et al.  HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease) , 2007, Nature Genetics.

[11]  J. Palmblad,et al.  Kostmann syndrome or infantile genetic agranulocytosis, part one: Celebrating 50 years of clinical and basic research on severe congenital neutropenia , 2006, Acta paediatrica.

[12]  Philip S Rosenberg,et al.  The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. , 2005, Blood.

[13]  J. Palmblad,et al.  Neutrophil elastase and granulocyte colony-stimulating factor receptor mutation analyses and leukemia evolution in severe congenital neutropenia patients belonging to the original Kostmann family in northern Sweden. , 2006, Haematologica.

[14]  W. Abdullah.  Pediatr Blood Cancer , 2004 .

[15]  Göran Carlsson,et al.  Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study , 2002, The Lancet.

[16]  A. Fasth,et al.  Infantile genetic agranulocytosis, morbus Kostmann: Presentation of six cases from the original “Kostmann family” and a review , 2001, Acta paediatrica.

[17]  C Bos,et al.  Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. , 2000, Blood.

[18]  Rolf Kostmann,et al.  INFANTILE GENETIC AGRANULOCYTOSIS , 1975 .

[19]  R. Kostman.  Infantile genetic agranulocytosis. A review with presentation of ten new cases. , 1975, Acta paediatrica Scandinavica.